I agree, Kevin. I also believe there will be multiple approaches, just as there are several different drug options to treat a headache (Tylenol, Advil, aspirin, etc). I am more interested in Sigma-1 in the broader context, if this is a new approach to treating illness and Anavex is the pioneer it will bode well for the long-term share price.